🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

That's a wrap 🎬 1️⃣ City of Roses 🌹 IBDHorizons X The Oregon Clinic Symposium. Thank you Dr Don Lum, all Faculty Speakers, Industry Partners and our fantastic, engaged Attendees. See you in 2025, PDX! #IBDHorizons24 Join us for an upcoming Symposium 🔗ibdhorizons.org

Less than a month away In person and virtual to attend. Come learn IBD from some of the best… and me

🗓️It's time for #ACG2024 abstracts, due 6/17! Dr. Anita Afzali MD, MPH, MHCM, FACG, AGAF issued the #ACGAbstractChallenge 📍Sponsor mentees on projects 📍Enhance scientific perspectives 📍Give 1st author to rising⭐️ 📍Share your work with collaboration, inclusivity, curiosity ➡️acgmeetings.gi.org⬅️

Insights in recent #IBD comparative trials ✅ How to optimize biologics and SM ✅ Does every #IBD patient need mucosal healing? ✅ #IBD updates from #DDW2024 ✅ Modern surgical management ✅ Star faculty line-up ✅ CME ✅ Join us 👇 swedishibd.com

Tomorrow June 1 👇🏼 👇🏼 👇🏼 👇🏼 Michael Chiorean Swedish Gastroenterology Remo Panaccione, MD, FRCPC Lindsay Sceats UW Medicine Newsroom UWGASTRO

It is finally here👇 swedishibd.com. One day left to register for our #IBD update. FOMO? We will have recordings and online syllabus for you to watch after the conference. See you all tomorrow morning Remo Panaccione, MD, FRCPC Scott D Lee, MD Swedish Gastroenterology Lindsay Sceats

Our keynote speaker Remo Panaccione, MD, FRCPC opening the Swedish Annual #IBD conference with a discussion about HTH comparative trials in #IBD - Saturday morning in Seattle

Head to head comparative trials are the way of the future in the field of #IBD so we need to learn to interpret differences in trial designs and endpoints Remo Panaccione, MD, FRCPC #SIBD_2024

Critical factors to consider when interpreting clinical trials Remo Panaccione, MD, FRCPC #SIBD_2024

#DrTimZisman Virginia Mason Franciscan Health teaching us about optimizing biologic drugs in #IBD; remember these 3 steps 👇for assessment and the SMART approach to shared decision making with patients #SIBD_2024

Dr Scott Lee Scott D Lee, MD educating us about combination advanced therapy CAT in #IBD #SIBD_24

Expectations of current #IBD therapies in 2024, and why do we need to break the "ceiling" of efficacy Scott D Lee, MD UW Medicine #SIBD_24

#DrKarleeAusk Swedish Gastroenterology teaching us why mucosal healing is fundamental to improving outcomes and why it should be a mutual decision with our #IBD patients #SIBD_2024

Dr Lindsay Sceats Lindsay Sceats Providence Swedish educating us about the role of surgery in the modern approach to #IBD #SIBD_2024

LIR!C applied globally: Early surgery for #crohnsdisease improves outcomes c/w delayed surgery in the large SURGICROHN-LATAM study from South America. Included patients w fibrostenotic disease Lindsay Sceats ##SIBD_2024

Surgery is not a failure in #IBD. Keep long-term goals in focus when talking to patients. Many patients feel sorry for not having it done earlier #SIBD_2024 Lindsay Sceats Providence Swedish

Anastomotic take home messages from Lindsay Sceats #SIBD_2024

Dr Iles-Shih Swedish Gastroenterology teaching us how to alleviate patient and provider concerns about using biosimilars in #IBD #SIBD_2024